Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Antineutrophil cytoplasmic antibodies and their relationship with disease activity and presence of staphylococcal superantigens in nasal swabs in patients having granulomatosis with polyangiitis: results of a study involving 115 patients from a single center.

Fijolek J, Wiatr E, Petroniec V, Augustynowicz-Kopec E, Bednarek M, Gawryluk D, Roszkowski-Sliz K.

Clin Rheumatol. 2019 Jul 23. doi: 10.1007/s10067-019-04693-0. [Epub ahead of print]

PMID:
31338700
2.

Tuberculosis transmission in the population of patients from the Krakow Region (Poland) based on the epidemiological and molecular methods.

Kruczak K, Augustynowicz-Kopeć E, Kozińska M, Passak-Stańda G, Niżankowska-Mogilnicka E, Sładek K.

Int J Mycobacteriol. 2019 Jan-Mar;8(1):60-69. doi: 10.4103/ijmy.ijmy_11_19.

3.

Nontuberculous mycobacteria strains isolated from patients between 2013 and 2017 in Poland. Our data with respect to the global trends.

Kwiatkowska S, Augustynowicz-Kopeć E, Korzeniewska-Koseła M, Filipczak D, Gruszczyński P, Zabost A, Klatt M, Sadkowska-Todys M.

Adv Respir Med. 2018 Dec 30. doi: 10.5603/ARM.a2018.0047. [Epub ahead of print]

4.

Factors predisposing to non-tuberculous mycobacterial lung disease in the patients with respiratory isolates of non-tuberculous mycobacteria.

Szturmowicz M, Siemion-Szcześniak I, Wyrostkiewicz D, Klatt M, Brzezińska S, Zabost A, Lewandowska A, Filipczak D, Oniszh K, Skoczylas A, Augustynowicz-Kopeć E, Kuś J.

Adv Respir Med. 2018 Dec 30. doi: 10.5603/ARM.a2018.0043. [Epub ahead of print]

5.

Treatment for active tuberculosis in giraffe (Giraffa camelopardalis) in a Zoo and potential consequences for public health - Case report.

Krajewska-Wędzina M, Augustynowicz-Kopeć E, Weiner M, Szulowski K.

Ann Agric Environ Med. 2018 Dec 19;25(4):593-595. doi: 10.26444/aaem/75685. Epub 2017 Jul 5.

6.

Drug Susceptibility of Non-tuberculous Strains of Mycobacterium Isolated from Birds from Poland.

Ledwoń A, Napiórkowska A, Augustynowicz-Kopeć E, Szeleszczuk P.

Pol J Microbiol. 2018;67(4):487-492. doi: 10.21307/pjm-2018-057.

PMID:
30550235
7.

Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.

Jagielski T, Bakuła Z, Brzostek A, Minias A, Stachowiak R, Kalita J, Napiórkowska A, Augustynowicz-Kopeć E, Żaczek A, Vasiliauskiene E, Bielecki J, Dziadek J.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e01093-18. doi: 10.1128/AAC.01093-18. Print 2018 Oct.

8.

Recommendations for the management of tuberculosis in children - KOMPASS TB. Part 1: Tuberculosis prevention.

Bielecka T, Augustynowicz-Kopeć E, Gonerko P, Gruszczyński P, Korzeniewska-Koseła M, Krasińska M, Krenke K, Lange J, Pankowska A, Popielarz M, Pustkowski A, Stryczyńska-Kazubska J, Doniec Z.

Adv Respir Med. 2018;86(3). doi: 10.5603/ARM.2018.0023.

PMID:
29960282
9.

The presence of staphylococcal superantigens in nasal swabs and correlation with activity of granulomatosis with polyangiitis in own material.

Fijołek J, Wiatr E, Petroniec V, Augustynowicz-Kopec E, Bednarek M, Gawryluk D, Martusewicz-Boros MM, Modrzewska K, Radzikowska E, Roszkowski-Sliz K.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):40-45. Epub 2018 May 4.

10.

Synthesis and Tuberculostatic Activity Evaluation of Novel Benzazoles with Alkyl, Cycloalkyl or Pyridine Moiety.

Krause M, Foks H, Augustynowicz-Kopeć E, Napiórkowska A, Szczesio M, Gobis K.

Molecules. 2018 Apr 23;23(4). pii: E985. doi: 10.3390/molecules23040985.

11.

Bovine tuberculosis outbreak in farmed American bison (Bison bison) in Poland.

Krajewska-Wędzina M, Olech W, Kozińska M, Augustynowicz-Kopeć E, Weiner M, Szulowski K.

Pol J Vet Sci. 2017 Dec;20(4):819-821. doi: 10.1515/pjvs-2017-0103.

PMID:
29611649
12.

Nontuberculous mycobacterial lung disease in a patient with COPD and bronchiectasis, with radiological signs of lung tumor.

Wyrostkiewicz D, Szturmowicz M, Bartoszuk I, Siemion-Szcześniak I, Jakubowska L, Augustynowicz-Kopeć E, Kuś J.

Adv Respir Med. 2018;86(1):17-22. doi: 10.5603/ARM.2018.0005.

13.

From Latent Tuberculosis Infection to Tuberculosis. News in Diagnostics (QuantiFERON-Plus).

Borkowska DI, Napiórkowska AM, Brzezińska SA, Kozińska M, Zabost AT, Augustynowicz-Kopeć EM.

Pol J Microbiol. 2017 Mar 30;66(1):5-8. doi: 10.5604/17331331.1234987.

PMID:
29359690
14.

The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains.

Sieniawska E, Sawicki R, Swatko-Ossor M, Napiorkowska A, Przekora A, Ginalska G, Augustynowicz-Kopec E.

Molecules. 2018 Jan 15;23(1). pii: E176. doi: 10.3390/molecules23010176.

15.

Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.

Augustynowicz-Kopeć E, Siemion-Szcześniak I, Zabost A, Wyrostkiewicz D, Filipczak D, Oniszh K, Gawryluk D, Radzikowska E, Korzybski D, Szturmowicz M.

Pol J Microbiol. 2019;68(1):15-19. doi: 10.21307/pjm-2019-002.

PMID:
31050249
16.

Molecular characterisation of Mycobacterium caprae strains isolated in Poland.

Krajewska-Wędzina M, Kozińska M, Orłowska B, Weiner M, Szulowski K, Augustynowicz-Kopeć E, Anusz K, Smith NH.

Vet Rec. 2018 Mar 10;182(10):292. doi: 10.1136/vr.104363. Epub 2017 Dec 6.

PMID:
29212913
17.

Evaluation of Susceptibility to Antimycobacterial Drugs in Mycobacterium Tuberculosis Complex Strains Isolated from Cattle in Poland.

Krajewska-Wędzina M, Zabost A, Augustynowicz-Kopeć E, Weiner M, Szulowski K.

J Vet Res. 2017 Apr 4;61(1):23-26. doi: 10.1515/jvetres-2017-0003. eCollection 2017 Mar.

18.

Leprosy - one of the many forgotten tropical diseases.

Zwolska Z, Augustynowicz-Kopeć E.

Postepy Hig Med Dosw (Online). 2017 Feb 14;71(0):69-77. Review.

19.

The incidence of tuberculosis transmission among family members and outside households.

Kozińska M, Augustynowicz-Kopeć E.

Pneumonol Alergol Pol. 2016;84(5):271-7. doi: 10.5603/PiAP.2016.0034.

20.

Intracardiac tuberculomas caused by Mycobacterium tuberculosis in a dog.

Szaluś-Jordanow O, Augustynowicz-Kopeć E, Czopowicz M, Olkowski A, Łobaczewski A, Rzewuska M, Sapierzyński R, Wiatr E, Garncarz M, Frymus T.

BMC Vet Res. 2016 Jun 14;12(1):109. doi: 10.1186/s12917-016-0731-7.

21.

Fungal infection of cystic fibrosis patients - single center experience.

Garczewska B, Jarzynka S, Kuś J, Skorupa W, Augustynowicz-Kopeć E.

Pneumonol Alergol Pol. 2016;84(3):151-9. doi: 10.5603/PiAP.2016.0017.

22.

What factors may influence epidemiological situation of tuberculosis in Poland and in the world?

Rowińska-Zakrzewska E, Korzeniewska-Koseła M, Augustynowicz-Kopeć E, Szturmowicz M.

Pneumonol Alergol Pol. 2016;84(2):126-33. doi: 10.5603/PiAP.2016.0013. Review.

23.

Transmission of tuberculosis among people living in the border areas of Poland, the Czech Republic, and Slovakia.

Kozińska M, Zientek J, Augustynowicz-Kopeć E, Zwolska Z, Kozielski J.

Pol Arch Med Wewn. 2016;126(1-2):32-40.

24.

Synthesis and Antimicrobial Activity of 4-Chloro-3-Nitrophenylthiourea Derivatives Targeting Bacterial Type II Topoisomerases.

Bielenica A, Stępień K, Napiórkowska A, Augustynowicz-Kopeć E, Krukowski S, Włodarczyk M, Struga M.

Chem Biol Drug Des. 2016 Jun;87(6):905-17. doi: 10.1111/cbdd.12723. Epub 2016 Feb 11.

PMID:
26804238
25.

Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates.

Jagielski T, Bakuła Z, Roeske K, Kamiński M, Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z, Bielecki J.

J Antimicrob Chemother. 2015 Dec;70(12):3214-21. doi: 10.1093/jac/dkv253. Epub 2015 Aug 25.

PMID:
26311839
26.

Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety.

Bielenica A, Stefańska J, Stępień K, Napiórkowska A, Augustynowicz-Kopeć E, Sanna G, Madeddu S, Boi S, Giliberti G, Wrzosek M, Struga M.

Eur J Med Chem. 2015 Aug 28;101:111-25. doi: 10.1016/j.ejmech.2015.06.027. Epub 2015 Jun 14.

PMID:
26119992
27.

Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.

Bakuła Z, Napiórkowska A, Kamiński M, Augustynowicz-Kopeć E, Zwolska Z, Bielecki J, Jagielski T.

J Microbiol Immunol Infect. 2016 Jun;49(3):439-44. doi: 10.1016/j.jmii.2015.04.003. Epub 2015 May 15.

28.

Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.

Gobis K, Foks H, Suchan K, Augustynowicz-Kopeć E, Napiórkowska A, Bojanowski K.

Bioorg Med Chem. 2015 May 1;23(9):2112-20. doi: 10.1016/j.bmc.2015.03.008. Epub 2015 Mar 9.

PMID:
25797161
29.

Antimicrobial and anti-biofilm activity of thiourea derivatives incorporating a 2-aminothiazole scaffold.

Stefanska J, Nowicka G, Struga M, Szulczyk D, Koziol AE, Augustynowicz-Kopec E, Napiorkowska A, Bielenica A, Filipowski W, Filipowska A, Drzewiecka A, Giliberti G, Madeddu S, Boi S, La Colla P, Sanna G.

Chem Pharm Bull (Tokyo). 2015;63(3):225-36. doi: 10.1248/cpb.c14-00837.

30.

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage.

Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S, Willery E, Blum MG, Rüsch-Gerdes S, Mokrousov I, Aleksic E, Allix-Béguec C, Antierens A, Augustynowicz-Kopeć E, Ballif M, Barletta F, Beck HP, Barry CE 3rd, Bonnet M, Borroni E, Campos-Herrero I, Cirillo D, Cox H, Crowe S, Crudu V, Diel R, Drobniewski F, Fauville-Dufaux M, Gagneux S, Ghebremichael S, Hanekom M, Hoffner S, Jiao WW, Kalon S, Kohl TA, Kontsevaya I, Lillebæk T, Maeda S, Nikolayevskyy V, Rasmussen M, Rastogi N, Samper S, Sanchez-Padilla E, Savic B, Shamputa IC, Shen A, Sng LH, Stakenas P, Toit K, Varaine F, Vukovic D, Wahl C, Warren R, Supply P, Niemann S, Wirth T.

Nat Genet. 2015 Mar;47(3):242-9. doi: 10.1038/ng.3195. Epub 2015 Jan 19.

PMID:
25599400
31.
32.
33.

Tuberculosis in Antelopes in a Zoo in Poland--Problem of Public Health.

Krajewska M, Załuski M, Zabost A, Orłowska B, Augustynowicz-Kopeć E, Anusz K, Lipiec M, Weiner M, Szulowski K.

Pol J Microbiol. 2015;64(4):395-7.

34.

PCR-based genomic deletion analysis of RD-regions in the identification of mycobacteria isolated from adverse events following BCG vaccination or TB suspected cases.

Krysztopa-Grzybowska K, Brzezińska S, Augustynowicz-Kopeć E, Augustynowicz E, Lutyńska A.

Pol J Microbiol. 2014;63(3):359-62.

35.

Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.

Gobis K, Foks H, Serocki M, Augustynowicz-Kopeć E, Napiórkowska A.

Eur J Med Chem. 2015 Jan 7;89:13-20. doi: 10.1016/j.ejmech.2014.10.031. Epub 2014 Oct 14.

PMID:
25462221
36.

Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides.

Antoszczak M, Maj E, Napiórkowska A, Stefańska J, Augustynowicz-Kopeć E, Wietrzyk J, Janczak J, Brzezinski B, Huczyński A.

Molecules. 2014 Nov 25;19(12):19435-59. doi: 10.3390/molecules191219435.

37.

Non-tuberculous mycobacterial lung disease (NT MLD ) in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.

Wilińska E, Oniszh K, Augustynowicz-Kopeć E, Zabost A, Fijałkowska A, Kurzyna M, Wieteska M, Torbicki A, Kuś J, Szturmowicz M.

Pneumonol Alergol Pol. 2014;82(6):495-502. doi: 10.5603/PiAP.2014.0066.

38.

Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.

Miotto P, Cabibbe AM, Feuerriegel S, Casali N, Drobniewski F, Rodionova Y, Bakonyte D, Stakenas P, Pimkina E, Augustynowicz-Kopeć E, Degano M, Ambrosi A, Hoffner S, Mansjö M, Werngren J, Rüsch-Gerdes S, Niemann S, Cirillo DM.

MBio. 2014 Oct 21;5(5):e01819-14. doi: 10.1128/mBio.01819-14.

39.

Bovine tuberculosis in a wild boar (Sus scrofa) in Poland.

Krajewska M, Lipiec M, Zabost A, Augustynowicz-Kopeć E, Szulowski K.

J Wildl Dis. 2014 Oct;50(4):1001-2. doi: 10.7589/2013-07-187. Epub 2014 Jul 30.

PMID:
25075538
40.

A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Jagielski T, Brzostek A, van Belkum A, Dziadek J, Augustynowicz-Kopeć E, Zwolska Z.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):41-53. doi: 10.1007/s10096-014-2202-z. Epub 2014 Jul 20.

PMID:
25037868
41.

[Microbiological diagnostics in the patients with cystic fibrosis].

Augustynowicz-Kopeć E.

Pneumonol Alergol Pol. 2014;82(4):327-9. doi: 10.5603/PiAP.2014.0040. Polish. No abstract available.

42.

Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland.

Jagielski T, Ignatowska H, Bakuła Z, Dziewit Ł, Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z, Bielecki J.

PLoS One. 2014 Jun 17;9(6):e100078. doi: 10.1371/journal.pone.0100078. eCollection 2014.

43.

Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.

Jagielski T, Bakuła Z, Roeske K, Kamiński M, Napiórkowska A, Augustynowicz-Kopeć E, Zwolska Z, Bielecki J.

J Antimicrob Chemother. 2014 Sep;69(9):2369-75. doi: 10.1093/jac/dku161. Epub 2014 May 22.

PMID:
24855126
44.

Experimental inoculation of BFDV-positive budgerigars (Melopsittacus undulatus) with two Mycobacterium avium subsp. avium isolates.

Ledwoń A, Sapierzyński R, Augustynowicz-Kopeć E, Szeleszczuk P, Kozak M.

Biomed Res Int. 2014;2014:418563. doi: 10.1155/2014/418563. Epub 2014 Mar 13.

45.

Characterisation of pyrazinamide-resistant Mycobacterium tuberculosis strains isolated in Poland and Germany.

Napiórkowska A, Rüsch-Gerdes S, Hillemann D, Richter E, Augustynowicz-Kopeć E.

Int J Tuberc Lung Dis. 2014 Apr;18(4):454-60. doi: 10.5588/ijtld.13.0457.

PMID:
24670702
46.

Mannan-binding lectin-associated serine protease-2 (MASP-2) deficiency in two patients with pulmonary tuberculosis and one healthy control.

Sokolowska A, Szala A, St Swierzko A, Kozinska M, Niemiec T, Blachnio M, Augustynowicz-Kopec E, Dziadek J, Cedzynski M.

Cell Mol Immunol. 2015 Jan;12(1):119-21. doi: 10.1038/cmi.2014.19. Epub 2014 Mar 24. No abstract available.

47.

Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland.

Bakuła Z, Napiórkowska A, Bielecki J, Augustynowicz-Kopeć E, Zwolska Z, Jagielski T.

Biomed Res Int. 2013;2013:167954. doi: 10.1155/2013/167954. Epub 2013 Dec 11.

48.

[Interferon-Gamma Release Assays in the diagnosis of latent tuberculosis infection in clinical situations].

Borkowska D, Radzikowska E, Załęska J, Ziołkowski J, Klatt M, Zwolska Z, Augustynowicz-Kopeć E, Roszkowski-Śliż K.

Pneumonol Alergol Pol. 2014;82(1):39-45. doi: 10.5603/PiAP.2014.0007. Polish.

49.

Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.

Zabost A, Brzezińska S, Kozińska M, Błachnio M, Jagodziński J, Zwolska Z, Augustynowicz-Kopeć E.

Biomed Res Int. 2013;2013:853602. doi: 10.1155/2013/853602. Epub 2013 Dec 7.

50.

[Transmission of Mycobacterium tuberculosis pre-XDR strains belonging to the Beijing family].

Kozińska M, Jakubowska M, Augustynowicz-Kopeć E.

Pol Merkur Lekarski. 2013 Jun;34(204):316-9. Polish.

PMID:
23882926

Supplemental Content

Loading ...
Support Center